Veradigm | MDRX - Capitaux D'Emprunt





Capitaux D'Emprunt Changement Date
Alcidion AUD 318K 376K 2025-12
Ambu A/S DKK 17M 3M 2026-03
Amplifon EUR 987.16M 121.99M 2025-12
Cardinal Health USD 8.25B 102M 2026-03
Centene USD 16.31B 1.04B 2026-03
Charles River Laboratories USD 2.66B 526.77M 2026-03
Cigna USD 29.37B 1.5B 2026-03
Coloplast 21.39B 1.34B 2025-12
Computer Programs Systems USD 161.24M 122K 2025-12
Convatec Group USD 1.18B 211.4M 2024-12
CVS Health USD 60.53B 29M 2026-03
Diasorin EUR 472.05M 199.95M 2025-06
Elevance Health USD 30.77B 29M 2026-03
General Electric Aerospace USD 18.17B 634M 2026-03
Gulf Medical Proj AED 3.1M 151K 2025-12
Humana USD 12.27B 95M 2026-03
IQVIA Holdings USD 13.99B 105M 2026-03
Laboratory Of America USD 5.9B 748.3M 2026-03
Maximus USD 1.47B 37.39M 2026-03
McKesson USD 5.26B 166M 2026-03
Med Life RON 1.71B 260.03M 2025-12
Molina Healthcare USD 3.77B 183M 2026-03
Omnicell USD 167.9M 303K 2026-03
Oriola-kd EUR 38.3M 600K 2025-12
Owens Minor USD 1.8B 35.38M 2025-12
Quest Diagnostics USD 5.16B 12M 2026-03
Rede D'or Sao Luiz BRL 47.03B 460.24M 2026-03
Siemens Healthineers EUR 11.42B 1.57B 2026-03
Sonova Holding CHF 1.39B 209.8M 2025-06
Supermax Corporation Bhd MYR 17.03M 581K 2025-12
UnitedHealth USD 71.44B 880M 2026-03
Veradigm USD 200.4M 69K 2022-12
Xerox USD 3.48B 785M 2025-06